2020, Cardiogenic Shock and Outcomes

Organ perfusion pressure predicts outcomes in cardiogenic shock patients

European Journal of Heart Failure

FEBRUARY 16, 2025

Organ perfusion pressure as a predictor of outcomes in cardiogenic shock: insights from the Altshock-2 registry. ABSTRACT Aims The diagnosis of cardiogenic shock (CS) relies upon signs and/or symptoms of end-organ hypoperfusion. The primary outcome was in-hospital all-cause mortality.

Cardiogenic Shock

Cardiogenic Shock Outcomes Myocardial Infarction Heart Failure

National Cardiogenic Shock Initiative Study Results Show Significant Increase in Heart Attack Survival

DAIC

DECEMBER 14, 2023

Henry Ford Health's National Cardiogenic Shock Initiative research team. Cardiogenic shock is a critical condition in which the heart is unable to pump enough blood to sustain the body’s needs, depriving vital organs of blood supply. Patients were enrolled between July 2016 and December 2020.

Cardiogenic Shock

Cardiogenic Shock Heart Attack Heart attacks Myocardial Infarction

Impella Versus Intra?Aortic Balloon Pump in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: An Observational Study

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundVenoarterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly used for patients with cardiogenic shock. Although Impella or intra‐aortic balloon pump (IABP) is frequently used for left ventricular unloading (LVU) during VA‐ECMO treatment, there are limited data on comparative outcomes. versus 25.8%;P‐trend<0.001).

Cardiogenic Shock

Cardiogenic Shock Aortic Hospital Outcomes

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Abstract 4146823: Trends and Outcomes in Heart Failure Admissions and Cardiogenic Shock Among Patients with Congenital Heart Disease

Circulation

NOVEMBER 11, 2024

CHD admissions remained stable from 2016 to 2020. Cardiogenic shock rates were highest among SV-CHD patients, with significant fluctuations, followed by DV-CHD patients. Variations in cardiogenic shock, MCS usage, and cardiac transplants emphasize the need for adaptive clinical practices to optimize patient outcomes.

Cardiogenic Shock

Cardiogenic Shock Congenital Heart Disease Heart Failure Congenital

Ventilation strategies in cardiogenic shock: Insights from the AltShock‐2 registry

European Journal of Heart Failure

DECEMBER 19, 2024

Ventilatory modalities in cardiogenic shock: insights from the AltShock-2 registry. Aims To describe the use and the relation to outcome of different ventilation strategies in a contemporary, large, prospective registry of cardiogenic shock patients.

Cardiogenic Shock

Cardiogenic Shock Cardiac Arrest Outcomes Research

Impella and venoarterial extracorporeal membrane oxygenation in cardiogenic shock complicating acute myocardial infarction

European Journal of Heart Failure

DECEMBER 13, 2023

Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with acute myocardial infarction-related cardiogenic shock (AMICS). Methods and results This nationwide observational cohort study describes all AMICS patients treated with Impella (ABIOMED, Danvers, MA, USA) and/or VA-ECMO in 2020–2021.

Cardiogenic Shock

Cardiogenic Shock Myocardial Infarction Cardiac Arrest Hospital

3 days of shoulder and chest pain, and now cardiogenic shock

Dr. Smith's ECG Blog

AUGUST 28, 2020

Now appears to be in cardiogenic shock." However, cardiogenic shock usually takes some time to develop, so it is probably subacute." Cardiogenic shock and ACS is an indication for the cath lab, even if you don't think there is OMI. I was texted these ECGs. Then SOB and nausea the next day.

Cardiogenic Shock

Cardiogenic Shock Chest Pain Ischemia Stenosis

Prevalence and outcomes of patients with SMuRF-less acute coronary syndrome undergoing percutaneous coronary intervention

Open Heart

JUNE 5, 2024

We aimed to investigate the prevalence and outcomes of patients with SMuRF-less ACS undergoing percutaneous coronary intervention (PCI) compared with those with SMuRFs. The primary outcome was 30-day mortality. Secondary outcomes included in-hospital and 30-day events. Secondary outcomes included in-hospital and 30-day events.

Cardiogenic Shock

Cardiogenic Shock Myocardial Infarction Outcomes Coronary Artery Disease

Abstract 4118341: Outcomes of Heart Failure with Preserved Ejection Fraction Patients With Concurrent Opioid Use: Insights From the National Inpatient Sample

Circulation

NOVEMBER 11, 2024

As heart failure with preserved ejection fraction (HFpEF) comprises half of all heart failure cases, understanding its management and effect on outcomes is crucial. There was a non-significant increased risk of cardiogenic shock (aOR 1.14, 95% CI 0.87 - 1.5, adjusted odds ratio [aOR] 1.01, 95% CI 0.85 - 1.2,

Preserved Ejection Fraction

Preserved Ejection Fraction Inpatient Cardiogenic Shock Heart Failure

Social Vulnerability and Long‐Term Cardiovascular Outcomes After COVID‐19 Hospitalization: An Analysis of the American Heart Association COVID‐19 Registry Linked With Medicare Claims Data

Journal of the American Heart Association

MARCH 21, 2025

However, the association of socioeconomic vulnerability and outcomes after hospitalization is uncertain.Methods and ResultsAmerican Heart Association COVID19 Cardiovascular Disease Registry hospitalizations between March 1, 2020, and June 30, 2022, linked with Medicare feeforservice claims, were analyzed.

COVID-19

COVID-19 Medicare Cardiogenic Shock Hospital

Outcomes of PCI of all comers: the experience of a Kuwaiti independent healthcare institution

The British Journal of Cardiology

APRIL 16, 2024

We present the cumulative percutaneous coronary intervention (PCI) data of all comers (stable angina and acute coronary syndromes [ACS]) who presented to Hadi Clinic between January 2018 and December 2020. A total of 567 patients underwent coronary catheterisation for the three-year period between January 2018 and December 2020.

Outcomes

Outcomes Cardiogenic Shock Angina STEMI

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

FEBRUARY 29, 2024

This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.

Aortic valve

Aortic valve Myocardial Infarction Aortic Blood Pressure

See this "NSTEMI" go unrecognized for what it really is, how it progresses, and what happens

Dr. Smith's ECG Blog

NOVEMBER 3, 2023

The notes now refer to the patient being in cardiogenic shock, on pressors. hours from presentation, where he was found to have an acute thrombotic LAD occlusion which was stented with resulting TIMI 3 flow, but still the patient was in severe cardiogenic shock. Academic Emergency Medicine 27(S1): S220; May 2020.

Chest Pain

Chest Pain Cardiogenic Shock Ischemia Myocardial Infarction

Chest pain and shock: Is there a right ventricular OMI on this ECG? And should he undergo trancutaneous pacing?

Dr. Smith's ECG Blog

MAY 30, 2023

The primary outcomes were sensitivity/specificity of 1) STD in lead I ≥ 0.5 mm and 2) STE in lead V1 ≥ 0.5 mm, stratified by presence or absence of posterior (inferobasal) MI, as determined by ≥0.5 mm STD in lead V2, for differentiating RVMI from non-RVMI. The February 11, 2020 post ( LA-RA reversal ).

Chest Pain

Chest Pain Myocardial Infarction STEMI Cardiogenic Shock

Extreme shock and cardiac arrest in COVID patient

Dr. Smith's ECG Blog

NOVEMBER 12, 2020

Assessment was severe sudden cardiogenic shock. Clin Chem [Internet] 2020;Available from: [link] Smith mini-review: Troponin in Emergency Department COVID patients Cardiac Troponin (cTn) is a nonspecific marker of myocardial injury. JAMA Cardiol [Internet] 2020;Available from: [link] 4. What is it? There is STE in V2-V6.

Cardiac Arrest

Cardiac Arrest COVID-19 Myocardial Infarction Cardiogenic Shock

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Contemporary characteristics, outcomes and novel risk score for Takotsubo cardiomyopathy: a national inpatient sample analysis

Open Heart

OCTOBER 7, 2024

We reviewed the characteristics and in-hospital outcomes and developed a novel risk score for TC. Methods Using the National Inpatient Sample data from 2016 to 2020, we identified adult patients (≥18 years) with acute coronary syndrome (ACS) and TC. We divided the cohort into ACS with and without TC and retrieved baseline data.

Inpatient

Inpatient Coronary Artery Bypass Graft Cardiomyopathy Cardiogenic Shock

Cardiovascular Update

Organ perfusion pressure predicts outcomes in cardiogenic shock patients

National Cardiogenic Shock Initiative Study Results Show Significant Increase in Heart Attack Survival

Impella Versus Intra?Aortic Balloon Pump in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: An Observational Study

Webinars

Abstract 4146823: Trends and Outcomes in Heart Failure Admissions and Cardiogenic Shock Among Patients with Congenital Heart Disease

Ventilation strategies in cardiogenic shock: Insights from the AltShock‐2 registry

Impella and venoarterial extracorporeal membrane oxygenation in cardiogenic shock complicating acute myocardial infarction

3 days of shoulder and chest pain, and now cardiogenic shock

Prevalence and outcomes of patients with SMuRF-less acute coronary syndrome undergoing percutaneous coronary intervention

Abstract 4118341: Outcomes of Heart Failure with Preserved Ejection Fraction Patients With Concurrent Opioid Use: Insights From the National Inpatient Sample

Social Vulnerability and Long‐Term Cardiovascular Outcomes After COVID‐19 Hospitalization: An Analysis of the American Heart Association COVID‐19 Registry Linked With Medicare Claims Data

Outcomes of PCI of all comers: the experience of a Kuwaiti independent healthcare institution

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

See this "NSTEMI" go unrecognized for what it really is, how it progresses, and what happens

Chest pain and shock: Is there a right ventricular OMI on this ECG? And should he undergo trancutaneous pacing?

Extreme shock and cardiac arrest in COVID patient

Published Research

Published Research

Contemporary characteristics, outcomes and novel risk score for Takotsubo cardiomyopathy: a national inpatient sample analysis

Stay Connected